Erratum to: Keratinocyte growth factor in acute lung injury to reduce pulmonary dysfunction - a randomised placebo-controlled trial (KARE): study protocol

Laurence J M Cross^{1

2}, Cecilia M O'Kane¹, Cliona McDowell³, Jospeh J Elborn¹, Michael A Matthay^{4

5}, Daniel F McAuley^{6

7}

Affiliations

¹ Centre for Infection and Immunity, The Queen's University of Belfast, Health Sciences, Building, 97 Lisburn Road, Belfast, BT9 7BL, Northern Ireland.
² Regional Intensive Care Unit, Royal Victoria Hospital, Belfast Health and Social Care Trust, Grosvenor Road, Belfast, BT12 6BA, Northern Ireland.
³ Clinical Research Support Centre, Royal Victoria Hospital, Belfast Health and Social Care Trust, Grosvenor Road, Belfast, BT12 6BA, Northern Ireland.
⁴ Cardiovascular Research Institute, University of California, San Francisco, 505 Parnassus Avenue, M-917, San Francisco, CA, 94143-0624, USA.
⁵ Departments of Medicine and Anesthesia, University of California, San Francisco, 505 Parnassus Avenue, San Francisco, CA, 94143, USA.
⁶ Centre for Infection and Immunity, The Queen's University of Belfast, Health Sciences, Building, 97 Lisburn Road, Belfast, BT9 7BL, Northern Ireland. d.f.mcauley@qub.ac.uk.
⁷ Regional Intensive Care Unit, Royal Victoria Hospital, Belfast Health and Social Care Trust, Grosvenor Road, Belfast, BT12 6BA, Northern Ireland. d.f.mcauley@qub.ac.uk.

Published Erratum

Laurence J M Cross et al. Trials. 2017.

. 2017 May 11;18(1):214.

doi: 10.1186/s13063-017-1930-7.

Laurence J M Cross^{1

2}, Cecilia M O'Kane¹, Cliona McDowell³, Jospeh J Elborn¹, Michael A Matthay^{4

5}, Daniel F McAuley^{6

7}

¹ Centre for Infection and Immunity, The Queen's University of Belfast, Health Sciences, Building, 97 Lisburn Road, Belfast, BT9 7BL, Northern Ireland.
² Regional Intensive Care Unit, Royal Victoria Hospital, Belfast Health and Social Care Trust, Grosvenor Road, Belfast, BT12 6BA, Northern Ireland.
³ Clinical Research Support Centre, Royal Victoria Hospital, Belfast Health and Social Care Trust, Grosvenor Road, Belfast, BT12 6BA, Northern Ireland.
⁴ Cardiovascular Research Institute, University of California, San Francisco, 505 Parnassus Avenue, M-917, San Francisco, CA, 94143-0624, USA.
⁵ Departments of Medicine and Anesthesia, University of California, San Francisco, 505 Parnassus Avenue, San Francisco, CA, 94143, USA.
⁶ Centre for Infection and Immunity, The Queen's University of Belfast, Health Sciences, Building, 97 Lisburn Road, Belfast, BT9 7BL, Northern Ireland. d.f.mcauley@qub.ac.uk.
⁷ Regional Intensive Care Unit, Royal Victoria Hospital, Belfast Health and Social Care Trust, Grosvenor Road, Belfast, BT12 6BA, Northern Ireland. d.f.mcauley@qub.ac.uk.

No abstract available

Erratum for

Keratinocyte growth factor in acute lung injury to reduce pulmonary dysfunction--a randomised placebo-controlled trial (KARE): study protocol.
Cross LJ, O'Kane CM, McDowell C, Elborn JJ, Matthay MA, McAuley DF. Cross LJ, et al. Trials. 2013 Feb 18;14:51. doi: 10.1186/1745-6215-14-51. Trials. 2013. PMID: 23419093 Free PMC article. Clinical Trial.

1. McAuley DF. Keratinocyte growth factor in acute lung injury to reduce pulmonary dysfunction – a randomised placebo-controlled trial (KARE): study protocol. Trials. 2013;14:10.1186/1745-6215-14-51. - PMC - PubMed